PLOW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. The chart is mildly bullish, but the risk/reward is unattractive for an impatient buyer because insiders are aggressively selling and the latest quarter showed a major earnings collapse despite higher revenue. I would stay on the sidelines until either price breaks and holds above ~38.23 (R1) with momentum, or fundamentals stabilize going into the 2026-02-24 earnings.
Trend/structure: Short-term trend is bullish with SMA_5 > SMA_20 > SMA_200, suggesting price is in an established uptrend. Momentum: MACD histogram is slightly positive (0.0115) but contracting, indicating upside momentum is fading rather than accelerating. RSI(6)=60 is neutral-to-slightly-bullish (not overbought), but not a strong momentum trigger. Key levels: Pivot ~37.19 (price 37.01 is slightly below pivot). Near-term support at S1 ~36.15 (then S2 ~35.50). Resistance at R1 ~38.23 (then R2 ~38.88). Practical read: With price below pivot and MACD contracting, this looks more like a “needs confirmation” setup than an aggressive buy point.
Intellectia Proprietary Trading Signals
Technical trend remains bullish via moving averages, with nearby support levels that could hold a pullback.
Revenue growth was strong in the latest quarter (+25.29% YoY), suggesting demand/recovery on the top line.
Options open interest is heavily call-leaning (OI put/call 0.15), implying investors are still positioned for upside.
Pattern-based projection indicates upside potential over 1 week/month (though not high confidence).
Insiders are Selling, with selling amount up ~2001.74% over the last month—strong negative signal versus a “buy now” decision.
Profitability deteriorated sharply: Net income and EPS both fell ~75% YoY in 2025/Q3, raising quality-of-earnings and margin/expense concerns.
Momentum is weakening (MACD histogram positive but contracting) and price sits slightly below the pivot, increasing odds of a near-term dip toward ~36.15 support.
No supportive event/news flow in the past week; next major catalyst is earnings (2026-02-24 after hours), which can introduce gap risk without a compensating edge.
No Intellectia buy signals (AI Stock Picker / SwingMax), reducing confidence in a “buy immediately” entry.
Latest reported quarter: 2025/Q3. Revenue rose to $162.121M (+25.29% YoY), but profitability collapsed: Net income $7.781M (-75.37% YoY) and EPS $0.33 (-75.74% YoY). Gross margin slipped to 22.55% (down ~0.22 YoY). Bottom line: strong top-line growth but major earnings compression—this weakens the case for chasing the stock immediately ahead of the next earnings on 2026-02-24 (Est. EPS 0.53).
No analyst rating or price target change data was provided in the dataset, so a recent trend in upgrades/downgrades cannot be confirmed here. In lieu of Street notes, the clearest “pros vs cons” read is: Pros—top-line growth and a technically bullish long-term structure. Cons—sharp YoY earnings decline and heavy insider selling, which typically weighs on institutional confidence.
